Posted 5th January 2026
Posted 4 months ago
By NHP Office
NHP Cellular Therapy Operational Group (CTG)
Learn more about the NHP Cellular Therapy Operational Group (CTG)
Posted 5th January 2026
Posted 19th November 2025
Posted 6 months ago
By Nhp
Posted 21st November 2024
Posted 1 year ago
By NHP Office
NHP 2023/2024 Annual Report
The NHP activity report for 2023/2024 (published 21 November 2024) gives an overview of its core and partner-related activities.
Posted 19th November 2024
Posted 1 year ago
By NHP Office
New NHP Chair Announced – Dr Kate Gardner
Following the stepping down of Professor Baba Inusa, Dr Kate Gardner has been appointed the new NHP Chair.
Posted 4th October 2024
Posted 2 years ago
By NHS England
NHS England on Oxbryta (Voxelotor) Withdrawal From the UK Market
NHS England sends a letter to centres regarding the 25.09.2024 withdrawal of Pfizer's Oxbryta (Voxelotor) drug for Sickle Cell Disorder.
Posted 19th June 2024
Posted 2 years ago
By NHP Office
World Sickle Cell Day 2024
For World Sickle Cell Awareness Day (19th June) 2024, we ask; 'Why try to reinvent the wheel?'
Posted 8th May 2024
Posted 2 years ago
By NHP Office
Posted 1st April 2024
Posted 2 years ago
By NHP Office
A Chapter Closes: Professor Baba Inusa Leaves the National Haemoglobinopathy Panel (NHP)
The Founding Chair of the NHP, Professor Baba Inusa, announces his departure from the NHS and his NHP Role in March 2024.
Posted 21st January 2024
Posted 2 years ago
By NHP Office
NHP 2022/2023 Annual Report
The NHP Annual Report is a summary of its activities and interactions.
